The global burden of trachoma: A review

PLoS Neglected Tropical Diseases

Volumn 3, Issue 10, 2009, Pages

  Burton, Matthew J ^a   Mabey, David C W ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; TETRAMYCIN;

BLINDNESS; CHLAMYDIA TRACHOMATIS; CLINICAL FEATURE; CONJUNCTIVA DISEASE; CORNEA OPACITY; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; ENDEMIC DISEASE; HEALTH CARE COST; HUMAN; PATHOGENESIS; PREVALENCE; QUALITY ADJUSTED LIFE YEAR; RECURRENT INFECTION; REVIEW; SINGLE DRUG DOSE; TRACHOMA; TRICHIASIS; WORLD HEALTH ORGANIZATION; ECONOMICS; HEALTH; PATHOLOGY; PATIENT;

BLINDNESS; HUMANS; TRACHOMA; VISUALLY IMPAIRED PERSONS; WORLD HEALTH;

EID: 70449504705     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000460     Document Type: Review

References (59)

1. Resnikoff S, Pascolini D, Mariotti SP, Pokharel GP (2008) Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. Bull World Health Organ 86: 63-70.
2. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, et al. (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82: 844-851.
3. World Health Organization (2003) Report of the 2nd global scientific meeting on trachoma. WHO/PBD/GET 03.1.
4. Barenfanger J (1975) Studies on the role of the family unit in the transmission of trachoma. Am J Trop Med Hyg 24: 509-515.
5. Burton MJ, Holland MJ, Faal N, Aryee EA, Alexander ND, et al. (2003) Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages. Invest Ophthalmol Vis Sci 44: 4215-4222. (Pubitemid 37186254)
6. El-Asrar AM, Van den Oord JJ, Geboes K, Missotten L, Emarah MH, et al. (1989) Immunopathology of trachomatous conjunctivitis. Br J Ophthalmol 73: 276-282.
7. Burton MJ, Bailey RL, Jeffries D, Mabey DC, Holland MJ (2004) Cytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic. Infect Immun 72: 7352-7356. (Pubitemid 39552413)
8. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR (1987) A simple system for the assessment of trachoma and its complications. Bull World Health Organ 65: 477-483. (Pubitemid 17161078)
9. Loomis WP, Starnbach MN (2002) T cell responses to Chlamydia trachomatis. Curr Opin Microbiol 5: 87-91.
10. Rottenberg ME, Gigliotti-Rothfuchs A, Wigzell H (2002) The role of IFNgamma in the outcome of chlamydial infection. Curr Opin Immunol 14: 444-451. (Pubitemid 34671246)
11. Bailey R, Duong T, Carpenter R, Whittle H, Mabey D (1999) The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiol Infect 123: 479-486. (Pubitemid 30076931)
12. Grassly NC, Ward ME, Ferris S, Mabey DC, Bailey RL (2008) The natural history of trachoma infection and disease in a Gambian cohort with frequent follow-up. PLoS Negl Trop Dis 2: e341. doi:10.1371/journal.pntd.0000341.
13. Wang SP, Grayston JT, Alexander ER (1967) Trachoma vaccine studies in monkeys. Am J Ophthalmol 63: Suppl-30.
14. Sowa S, Sowa J, Collier LH, Blyth WA (1969) Trachoma vaccine field trials in The Gambia. J Hyg (Lond) 67: 699-717.
15. Hanna L, Jawetz E, Dawson CR, Thygeson P (1982) Long-term clinical, microbiological, and immunological observations of a volunteer repeatedly infected with Chlamydia trachomatis. J Clin Microbiol 16: 895-900.
16. Dawson CR, Marx R, Daghfous T, Juster R, Schachter J (1990) What clinical signs are critical in evaluating the intervention in trachoma? Bowie WR, ed. Chlamydial Infections. Cambridge: Cambridge University Press. pp 271-278.
17. West SK, Munoz B, Mkocha H, Hsieh YH, Lynch MC (2001) Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiol 8: 137-144. (Pubitemid 32692558)
18. Natividad A, Wilson J, Koch O, Holland MJ, Rockett K, et al. (2005) Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci. Genes Immun 6: 332-340.
19. Natividad A, Cooke G, Holland MJ, Burton MJ, Joof HM, et al. (2006) A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection. BMC Med Genet 7: 40. (Pubitemid 44110343)
20. Natividad A, Hanchard N, Holland MJ, Mahdi OS, Diakite M, et al. (2007) Genetic variation at the TNF locus and the risk of severe sequelae of ocular Chlamydia trachomatis infection in Gambians. Genes Immun 8: 288-295. (Pubitemid 46888036)
21. Burton MJ, Kinteh F, Jallow O, Sillah A, Bah M, et al. (2005) A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia. Br J Ophthalmol 89: 1282-1288. (Pubitemid 41638866)
22. Polack S, Brooker S, Kuper H, Mariotti S, Mabey D, et al. (2005) Mapping the global distribution of trachoma. Bull World Health Organ 83: 913-919.
23. Taylor HR (2008) Trachoma: a blinding scourge from the Bronze Age to the twenty-first century. Melbourne: Centre for Eye Research Australia.
24. Courtright P, Sheppard J, Schachter J, Said ME, Dawson CR (1989) Trachoma and blindness in the Nile Delta: current patterns and projections for the future in the rural Egyptian population. Br J Ophthalmol 73: 536-540. (Pubitemid 19184503)
25. West SK, Munoz B, Turner VM, Mmbaga BB, Taylor HR (1991) The epidemiology of trachoma in central Tanzania. Int J Epidemiol 20: 1088-1092.
26. Ngondi J, Reacher MH, Matthews FE, Brayne C, Gatpan G, et al. (2008) Risk factors for trachomatous trichiasis in children: cross-sectional household surveys in Southern Sudan. Trans R Soc Trop Med Hyg 103: 305-314.
27. Dolin PJ, Faal H, Johnson GJ, Ajewole J, Mohamed AA, et al. (1998) Trachoma in The Gambia. Br J Ophthalmol 82: 930-933.
28. Emerson PM, Cairncross S, Bailey RL, Mabey DC (2000) Review of the evidence base for the 'F' and 'E' components of the SAFE strategy for trachoma control. Trop Med Int Health 5: 515-527.
29. Emerson PM, Lindsay SW, Alexander N, Bah M, Dibba SM, et al. (2004) Role of flies and provision of latrines in trachoma control: cluster-randomised controlled trial. Lancet 363: 1093-1098. (Pubitemid 38452780)
30. Schachter J, Dawson CR (1990) The epidemiology of trachoma predicts more blindness in the future. Scand J Infect Dis Suppl 69: 55-62.
31. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY (1995) Global data on blindness. Bull World Health Organ 73: 115-121.
32. Dawson CR, Jones BR, Tarizzo ML (1981) Guide to trachoma control. Geneva: World Health Organization.
33. Frick KD, Basilion EV, Hanson CL, Colchero MA (2003) Estimating the burden and economic impact of trachomatous visual loss. Ophthalmic Epidemiol 10: 121-132. (Pubitemid 36408316)
34. Ranson MK, Evans TG (1995) The global burden of trachomatous visual impairment: I. Assessing prevalence. Int Ophthalmol 19: 261-270.
35. Thylefors B, Negrel AD, Pararajasegaram R (1992) [Epidemiological surveillance of trachoma: evaluation and perspective]. Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique 69: 107-114.
36. Mariotti SP, Pascolini D, Rose-Nussbaumer J (2009) Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol 93: 563-568.
37. Berhane Y, Worku A, Bejiga A (2006) National Survey on Blindness, Low Vision and Trachoma in Ethiopia. Addis Ababa: Addis Ababa: Ministry of Health.
38. Ngondi J, Ole-Sempele F, Onsarigo A, Matende I, Baba S, et al. (2006) Blinding trachoma in postconflict southern Sudan. PLoS Med 3: e478. doi:10.1371/ journal.pmed.0030478.
39. Frick KD, Melia BM, Buhrmann RR, West SK (2001) Trichiasis and disability in a trachoma-endemic area of Tanzania. Arch Ophthalmol 119: 1839-1844.
40. Frick KD, Hanson CL, Jacobson GA (2003) Global burden of trachoma and economics of the disease. Am J Trop Med Hyg 69: 1-10.
41. Murray CJL, Lopez AD (1996) The Global Burden of Disease: a comprehensive assessment of mortality and disability from disease, injuries and risk factors in 1990 and projected to 2020. Cambridge: Harvard University Press.
42. Mathers CD, Ezzati M, Lopez AD (2007) Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis 1: e114. doi:10.1371/journal.pntd.0000114.
43. Evans TG, Ranson MK (1995) The global burden of trachomatous visual impairment: II. Assessing burden. Int Ophthalmol 19: 271-280.
44. Taylor HR, Katala S, Munoz B, Turner V (1991) Increase in mortality associated with blindness in rural Africa. Bull World Health Organ 69: 335-338.
45. Kirkwood B, Smith P, Marshall T, Prost A (1983) Relationships between mortality, visual acuity and microfilarial load in the area of the Onchocerciasis Control Programme. Trans R Soc Trop Med Hyg 77: 862-868.
46. World Health Organization (1998) Global elimination of blinding trachoma. Resolution WHA 51.11. Adopted by the World Health Assembly 16 May 1998.
47. Francis V, Turner V (1993) Achieving community support for trachoma control. WHO/PBL/ 93.36.
48. Sumamo E, Emerson PM, Harvey C, Burton MJ (2007) The Cochrane Library and Trachoma: an overview of reviews. Evid Based Child Health 2: 943-964.
49. Yorston D, Mabey D, Hatt S, Burton M (2006) Interventions for trachoma trichiasis. Cochrane Database Syst Rev. pp CD004008.
50. West ES, Mkocha H, Munoz B, Mabey D, Foster A, et al. (2005) Risk factors for postsurgical trichiasis recurrence in a trachoma-endemic area. Invest Ophthalmol Vis Sci 46: 447-453. (Pubitemid 40270321)
51. Schachter J, West SK, Mabey D, Dawson CR, Bobo L, et al. (1999) Azithromycin in control of trachoma. Lancet 354: 630-635.
52. Evans TG, Ranson MK, Kyaw TA, Ko CK (1996) Cost effectiveness and cost utility of preventing trachomatous visual impairment: lessons from 30 years of trachoma control in Burma. Br J Ophthalmol 80: 880-889.
53. Frick KD, Keuffel EL, Bowman RJ (2001) Epidemiological, demographic, and economic analyses: measurement of the value of trichiasis surgery in The Gambia. Ophthalmic Epidemiol 8: 191-201.
54. Baltussen RM, Sylla M, Frick KD, Mariotti SP (2005) Cost-effectiveness of trachoma control in seven world regions. Ophthalmic Epidemiol 12: 91-101. (Pubitemid 41702822)
55. Solomon AW, Holland MJ, Alexander ND, Massae PA, Aguirre A, et al. (2004) Mass treatment with single-dose azithromycin for trachoma. N Engl J Med 351: 1962-1971. (Pubitemid 39447137)
56. Burton MJ, Holland MJ, Makalo P, Aryee EA, Alexander ND, et al. (2005) Reemergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet 365: 1321-1328. (Pubitemid 40501294)
57. World Health Organization (1992) International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva: World Health Organization.
58. World Health Organization (2004) World Health Report 2004. Changing History.
59. World Health Organization (2008) The Global Burden of Disease: 2004 update.